Health
Ex-Pfizer employee charged with illegal trading based on unreleased Covid pill trial data
Federal authorities charged a former Pfizer employee and his close friend Thursday with illegally trading shares based on non-public trial results on the pharmaceutical company’s Covid antiviral pill Paxlovid. The Justice Department and the Securities and Exchange Commission both announced respective insider trading charges against Amit Dagar, a former senior statistical programming lead at Pfizer, […]
Read More
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images The Centers for Disease Control and Prevention on Thursday recommended that adults ages 60 and above receive a single dose of RSV vaccines from Pfizer and GSK after consulting their doctors. Outgoing CDC Director Rochelle Walensky signed off on the recommendation, which an advisory panel […]
Read More
Justice Department charges 78 people with $2.5 billion in health-care fraud
U.S. Attorney General Merrick Garland speaking on June 22, 2023 in Washington, DC. Chip Somodevilla | Getty Images The Justice Department on Wednesday charged 78 people with $2.5 billion in health-care fraud. The DOJ, in a press release, said the defendants allegedly defrauded programs used to take care of elderly and disabled people. In some […]
Read More
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
An Eli Lilly & Co. logo is seen on a box of insulin medication in this arranged photograph at a pharmacy in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Drugmakers are jockeying to capitalize on the next major innovation coming to the blockbuster weight loss industry: effective, convenient and potentially affordable obesity pills. […]
Read More
Eli Lilly’s weight loss drugs trounce sky-high expectations, boosting the stock
Eli Lilly bested investors’ super-high expectations at the American Diabetes Association conference this week, cementing its leadership in metabolic medicine and prompting Wall Street analysts to take another look at their sales forecasts. Across the board, analysts said the news is likely to lend support Lillto y shares, which have already popped more than 26% […]
Read More
Don’t budget, says financial psychologist. Here’s why he recommends a ‘spending plan’ instead
Everything that makes up your personhood — your values, experiences and culture — directly affects your spending habits more than you might think. “Financial psychology is about the humanness of money: how people think, feel, behave about their money [and] their relationship with money in the past, present and future,” said financial psychologist Preston […]
Read More
Walgreens slashes earnings guidance due to lower consumer spending, drop in Covid care demand
People make their way near a Walgreens pharmacy on March 09, 2023 in New York City. Leonardo Munoz | Corbis News | Getty Images Walgreens on Tuesday slashed its full-year earnings guidance as it fell short of Wall Street expectations for its fiscal third quarter due to lower consumer spending and a drop in demand […]
Read More
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest reduction seen in the obesity treatment space to date, according to new mid-stage clinical trial results released Monday. […]
Read More
Britain’s underfunded National Health Service linked to earlier deaths, study says
The NHS has come under increasing pressure over recent years due to higher demand for services and funding and personnel shortages — issues further exacerbated by the Covid-19 pandemic. Bloomberg | Getty Images Chronic underinvestment in the U.K.’s National Health Service means Britons are likely to die sooner from serious diseases than patients in other […]
Read More
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Monday said it would stop developing its experimental obesity and diabetes pill, lotiglipron, due to elevated liver enzymes in patients who took the drug once a day in mid-stage clinical studies. Those elevated enzymes often indicate damage to cells in the liver, but the pharmaceutical giant […]
Read More